China Wacan: 2025 Revenue Up 13.6% to HK$124.95 Million; Net Loss Narrows to HK$14.45 Million

Bulletin Express03-31

China Wacan Group Company Limited (China Wacan, 01920) released its audited results for the year ended 31 December 2025.

Revenue and Profitability • Revenue increased 13.6% year on year to HK$124.95 million, driven mainly by higher Construction Services turnover and the first-time contribution of HK$8.90 million from the new Beauty & Health Services segment. • Gross profit recovered to HK$10.02 million from a gross loss of HK$12.88 million in 2024, lifting the gross margin to 8.0% from negative 11.7%. • Reversal of expected credit losses totalled HK$2.35 million versus a HK$21.51 million charge in 2024. • Administrative expenses rose 199.5% to HK$26.72 million, reflecting higher professional fees, staff costs and rental expenses. • Finance costs climbed 114.5% to HK$0.46 million due to lease-related interest. • Loss attributable to shareholders narrowed 76.7% to HK$10.09 million (loss per share: 2.93 HK cents), compared with a HK$43.34 million loss (13.89 HK cents) a year earlier.

Segment Performance • Construction Services remained the core contributor, generating HK$116.04 million revenue and HK$7.27 million segment profit. • Beauty & Health Services, launched in 2025 with 67 physical stores across major Chinese cities, reported HK$8.90 million revenue but a HK$13.96 million segment loss, reflecting start-up costs. • Construction IT Services had no revenue during the year (2024: HK$0.37 million).

Balance Sheet and Liquidity • Cash and cash equivalents increased to HK$31.12 million (2024: HK$10.54 million), while all bank borrowings were fully repaid by year-end. • Net assets rose to HK$14.20 million from HK$9.83 million. • Gearing ratio (total interest-bearing liabilities and related party loan to total equity) stood at 71.1% (2024: 54.0%), reflecting the addition of HK$2.00 million due to a related-party payable and HK$8.09 million in lease liabilities.

Capital Activities • In June 2025 the company placed 62.40 million new shares at HK$0.241 each, raising gross proceeds of HK$15.04 million; net proceeds of HK$14.10 million were fully utilised for expansion of the beauty business, office renovation and working capital. • A connected subscription agreement for 112.32 million new shares at HK$0.3965 each was approved in February 2026; completion is pending. • The authorised share capital was increased to HK$120 million (1.20 billion shares).

Operational Highlights • Order book for ongoing wet-trade projects totalled approximately HK$273.40 million at 31 December 2025; bids for five additional contracts worth about HK$152.20 million were pending. • Employee headcount expanded to 260 (2024: 13) to support the new beauty segment; total staff costs rose to HK$15.34 million (2024: HK$5.04 million).

Dividend • No final dividend was declared for 2025 (2024: nil).

Governance and Other Developments • HLB Hodgson Impey Cheng Limited was appointed as the new external auditor in December 2025, replacing Wilson & Partners CPA. • The company reported full compliance with the Corporate Governance Code and maintained the required public float throughout the year.

Outlook Management signalled a cautious stance toward Hong Kong’s construction market amid subdued developer activity, while focusing on maintaining market share in wet-trade services and accelerating the rollout of beauty and health stores across Mainland China to diversify revenue streams.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment